Urea Cycle Disorder Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Urea Cycle Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders

Urea Cycle Disorders
Tongji Hospital40 enrolled5 locationsNCT06904027
Recruiting
Not Applicable

Ureagenesis Analysis in Healthy Subjects and in Urea Cycle Disorder Patients

Urea Cycle Disorders
University Children's Hospital, Zurich100 enrolled1 locationNCT05671666
Recruiting
Phase 1Phase 2

An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency

Ornithine Transcarbamylase DeficiencyOrnithine Transcarbamylase Deficiency DiseaseUrea Cycle Disorders, Inborn+1 more
iECURE, Inc.8 enrolled10 locationsNCT06255782
Recruiting

Hepatic Histopathology in Urea Cycle Disorders

Urea Cycle DisorderOrnithine Transcarbamylase DeficiencyCitrullinemia 1+7 more
Baylor College of Medicine70 enrolled2 locationsNCT04908319
Recruiting

Liver Disease in Urea Cycle Disorders

Urea Cycle DisorderOrnithine Transcarbamylase DeficiencyCitrullinemia 1+5 more
Baylor College of Medicine62 enrolled5 locationsNCT04612764
Recruiting

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

Ornithine Transcarbamylase DeficiencyOrnithine Transcarbamylase Deficiency DiseaseUrea Cycle Disorders, Inborn
iECURE, Inc.13 enrolled1 locationNCT06805695
Recruiting

Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

Urea Cycle Disorders
Children's National Research Institute56 enrolled1 locationNCT02935283
Recruiting

Longitudinal Study of Urea Cycle Disorders

Brain Diseases, Metabolic, InbornAmino Acid Metabolism, Inborn ErrorsUrea Cycle Disorders
Andrea Gropman1,500 enrolled15 locationsNCT00237315
Recruiting

Systemic Biomarkers of Brain Injury From Hyperammonemia

Urea Cycle DisorderOrganic AcidemiaMaple Syrup Urine Disease+2 more
Children's National Research Institute24 enrolled1 locationNCT04602325